1
|
Kumar M, Kumar S, Kumar R, Jha MK, Tiwari SN, Gupta P. Serious Concern of Congenital Zika Syndrome (CZS) in India: A Narrative Review. J Pregnancy 2024; 2024:1758662. [PMID: 38961858 PMCID: PMC11221965 DOI: 10.1155/2024/1758662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2024] [Revised: 05/16/2024] [Accepted: 05/21/2024] [Indexed: 07/05/2024] Open
Abstract
Congenital Zika syndrome (CZS) is a major concern in India and highlights the multifaceted challenges posed by the Zika virus (ZIKV). The alarming increase in CZS cases in India, a condition that has serious effects on both public health and newborns, has raised concerns. This review highlights the importance of raising concern and awareness and taking preventive measures by studying the epidemiology, clinical symptoms, and potential long-term consequences of CZS. The review also contributes to worldwide research and information sharing to improve the understanding and prevention of CZS. As India deals with the changing nature of CZS, this thorough review is an important tool for policymakers, health workers, and researchers to understand what is happening now, plan for what to do in the future, and work together as a team, using medical knowledge, community involvement, and study projects to protect newborns' health and reduce the public health impact of these syndromes.
Collapse
Affiliation(s)
- Maneesh Kumar
- State-Viral Research and Diagnositic LaboratoryDepartment of MicrobiologyAll India Institute of Medical Sciences, Deoghar 814152, Jharkhand, India
| | - Suman Kumar
- Department of MicrobiologyAll India Institute of Medical Sciences, Deoghar 814152, Jharkhand, India
| | - Ratnesh Kumar
- Department of MicrobiologyAll India Institute of Medical Sciences, Deoghar 814152, Jharkhand, India
| | - Mithilesh Kumar Jha
- Department of MicrobiologyAll India Institute of Medical Sciences, Deoghar 814152, Jharkhand, India
| | - Shashank Nand Tiwari
- State-Viral Research and Diagnositic LaboratoryDepartment of MicrobiologyAll India Institute of Medical Sciences, Deoghar 814152, Jharkhand, India
| | - Pratima Gupta
- Department of MicrobiologyAll India Institute of Medical Sciences, Deoghar 814152, Jharkhand, India
| |
Collapse
|
2
|
Sapkal G, Deshpande GR, Gupta N, Deshpande K, Sharma S, Tandale B, Srivastava R, Vidhate S, Khutwad K, Tilekar BN. Harmonization of Zika serological assays and comparative evaluation of two commercial ZIKA IgG ELISA kits. Diagn Microbiol Infect Dis 2024; 109:116238. [PMID: 38554539 DOI: 10.1016/j.diagmicrobio.2024.116238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2023] [Revised: 01/27/2024] [Accepted: 02/27/2024] [Indexed: 04/01/2024]
Abstract
The interpretation for Zika virus serology results is challenging due to high antibody cross reactivity with other flaviviruses. This limits availability of reliable and accurate methods for serosurveillance studies to understand the disease burden. Therefore, we conducted study to harmonize anti-Zika IgG antibody detection assays with 1st WHO International Standard (16/352) and working standard (16/320) for anti-Zika virus antibody.Additionally, evaluated NuGenTMZIKA-IgG and NovaLisa®ZIKA virus IgG-Capture ELISA using a panel of 278 seraFurther, 106 samples positive for other-flavi viruses were taken for assessing cross-reactivity of the assay, all serums were further tested by Zika-PRNT. The results of this study indicates satisfactory performance of both the assays. Serological and neutralization assays were calibrated according to the international standards. This will help in understanding antibody dynamics in serosurveillance and vaccine studies. However the performance of the kits with possibilities of cross-reactivity will have to be verified by coupling ZIKV and DENV specific ELISA.
Collapse
Affiliation(s)
- Gajanan Sapkal
- ICMR-National Institute of Virology, Pune 411021, Maharashtra, India.
| | | | - Nivedita Gupta
- Indian Council of Medical Research, New Delhi 110001,India
| | - Ketki Deshpande
- ICMR-National Institute of Virology, Pune 411021, Maharashtra, India
| | - Sharada Sharma
- ICMR-National Institute of Virology, Pune 411021, Maharashtra, India
| | - Babasaheb Tandale
- ICMR-National Institute of Virology, Pune 411021, Maharashtra, India
| | - Rashi Srivastava
- ICMR-National Institute of Virology, Pune 411021, Maharashtra, India
| | - Shankar Vidhate
- ICMR-National Institute of Virology, Pune 411021, Maharashtra, India
| | - Kirtee Khutwad
- ICMR-National Institute of Virology, Pune 411021, Maharashtra, India
| | - B N Tilekar
- ICMR-National Institute of Virology, Pune 411021, Maharashtra, India
| |
Collapse
|
3
|
Chandra V, Gaidhane A, Choudhari SG. Public Health Strategies in the Face of Crisis: A Comprehensive Review of the Zika Outbreak in India. Cureus 2024; 16:e58621. [PMID: 38770475 PMCID: PMC11103263 DOI: 10.7759/cureus.58621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2024] [Accepted: 04/19/2024] [Indexed: 05/22/2024] Open
Abstract
This review provides a comprehensive analysis of the public health strategies employed during the Zika outbreak in India, focusing on the identification, surveillance, and containment efforts. The multifaceted approach, including vector control measures, healthcare infrastructure enhancement, and public communication strategies, played a pivotal role in mitigating the impact of the virus. Government policies and international collaborations emerged as influential factors, underscoring the significance of a coordinated response to infectious disease crises. The study emphasizes the importance of ongoing vigilance and preparedness in public health systems, acknowledging the dynamic nature of emerging infectious diseases. The Zika outbreak in India serves as a valuable case study, offering insights into the strengths and weaknesses of crisis management responses. As the global community faces ongoing health challenges, the lessons learned from this review contribute to refining strategies, improving coordination, and fostering a proactive and resilient approach to safeguarding public health.
Collapse
Affiliation(s)
- Vaibhav Chandra
- Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND
| | - Abhay Gaidhane
- Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND
| | - Sonali G Choudhari
- Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND
| |
Collapse
|
4
|
Patar AK, Borah SM, Barman J, Bora A, Baruah TJ. Dronabinol as an answer to flavivirus infections: an in-silico investigation. J Biomol Struct Dyn 2023; 41:11219-11230. [PMID: 36576139 DOI: 10.1080/07391102.2022.2160817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2021] [Accepted: 12/15/2022] [Indexed: 12/29/2022]
Abstract
Flavivirus infections are common in several parts of the world. Two major types of flaviviruses are dengue and zika viruses. Both these two viral infections have caused many fatalities around the world. There is an absence of a vaccine and an effective medication against these viruses. In this study, we analyzed the ability of dronabinol to act as a potential cure against these viral infections. We performed the docking of dronabinol with several viral proteins followed by molecular dynamics simulation, MM/PBSA and PCA analysis. We checked the ability of the polyphenol dronabinol to interfere with the binding of viral helicases to their cellular targets. We performed 2 D-QSAR studies, drug likeliness, ADMET and target prediction studies. From our study, we observed that dronabinol had the best docking ability against the helicase proteins of dengue and zika. Molecular dynamics simulation and MM/PBSA investigation confirmed the stability of the binding while PCA investigation showed a lowering of molecular motions in response to dronabinol docking to the helicases. Dronabinol interfered in the binding of the helicases to RNA. 2 D QSAR studies revealed a low IC50 value for dronabinol. Dronabinol showed favorable drug-likeness, ADMET properties and target prediction results. Thus we propose dronabinol be further investigated in-vitro as a cure against dengue and zika virus infections.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Abani Kumar Patar
- Department of Biochemistry, Assam Royal Global University, Guwahati, Assam, India
| | - Sapna Mayuri Borah
- Department of Plant Pathology, Assam Agricultural University, Jorhat, Assam, India
| | - Jitul Barman
- Department of Biochemistry, Assam Royal Global University, Guwahati, Assam, India
| | - Anupam Bora
- Department of Biochemistry, Assam Royal Global University, Guwahati, Assam, India
| | - Taranga Jyoti Baruah
- Department of Biochemistry, Assam Royal Global University, Guwahati, Assam, India
| |
Collapse
|
5
|
Anantharaj A, Agrawal T, Shashi PK, Tripathi A, Kumar P, Khan I, Pareek M, Singh B, Pattabiraman C, Kumar S, Pandey R, Chandele A, Lodha R, Whitehead SS, Medigeshi GR. Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection. COMMUNICATIONS MEDICINE 2023; 3:148. [PMID: 37857747 PMCID: PMC10587183 DOI: 10.1038/s43856-023-00378-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2023] [Accepted: 10/04/2023] [Indexed: 10/21/2023] Open
Abstract
BACKGROUND India is hyperendemic to dengue and over 50% of adults are seropositive. There is limited information on the association between neutralizing antibody profiles from prior exposure and viral RNA levels during subsequent infection. METHODS Samples collected from patients with febrile illness was used to assess seropositivity by indirect ELISA. Dengue virus (DENV) RNA copy numbers were estimated by quantitative RT-PCR and serotype of the infecting DENV was determined by nested PCR. Focus reduction neutralizing antibody titer (FRNT) assay was established using Indian isolates to measure the levels of neutralizing antibodies and also to assess the cross-reactivity to related flaviviruses namely Zika virus (ZIKV), Japanese encephalitis virus (JEV) and West Nile virus (WNV). RESULTS In this cross-sectional study, we show that dengue seropositivity increased from 52% in the 0-15 years group to 89% in >45 years group. Antibody levels negatively correlate with dengue RNAemia on the day of sample collection and higher RNAemia is observed in primary dengue as compared to secondary dengue. The geometric mean FRNT50 titers for DENV-2 is significantly higher as compared to the other three DENV serotypes. We observe cross-reactivity with ZIKV and significantly lower or no neutralizing antibodies against JEV and WNV. The FRNT50 values for international isolates of DENV-1, DENV-3 and DENV-4 is significantly lower as compared to Indian isolates. CONCLUSIONS Majority of the adult population in India have neutralizing antibodies to all the four DENV serotypes which correlates with reduced RNAemia during subsequent infection suggesting that antibodies can be considered as a good correlate of protection.
Collapse
Affiliation(s)
- Anbalagan Anantharaj
- Bioassay laboratory and Clinical and Cellular Virology lab, Translational Health Science and Technology Institute, Faridabad, Haryana, India
| | - Tanvi Agrawal
- Bioassay laboratory and Clinical and Cellular Virology lab, Translational Health Science and Technology Institute, Faridabad, Haryana, India
| | - Pooja Kumari Shashi
- Bioassay laboratory and Clinical and Cellular Virology lab, Translational Health Science and Technology Institute, Faridabad, Haryana, India
| | - Alok Tripathi
- Bioassay laboratory and Clinical and Cellular Virology lab, Translational Health Science and Technology Institute, Faridabad, Haryana, India
| | - Parveen Kumar
- Bioassay laboratory and Clinical and Cellular Virology lab, Translational Health Science and Technology Institute, Faridabad, Haryana, India
| | - Imran Khan
- Bioassay laboratory and Clinical and Cellular Virology lab, Translational Health Science and Technology Institute, Faridabad, Haryana, India
| | - Madhu Pareek
- Bioassay laboratory and Clinical and Cellular Virology lab, Translational Health Science and Technology Institute, Faridabad, Haryana, India
| | - Balwant Singh
- Bioassay laboratory and Clinical and Cellular Virology lab, Translational Health Science and Technology Institute, Faridabad, Haryana, India
| | | | - Saurabh Kumar
- Bioassay laboratory and Clinical and Cellular Virology lab, Translational Health Science and Technology Institute, Faridabad, Haryana, India
| | - Rajesh Pandey
- INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, Division of Immunology and Infectious Disease Biology, CSIR-Institute of Genomics and Integrative Biology, Delhi, India
| | - Anmol Chandele
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, India
| | - Rakesh Lodha
- Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India
| | - Stephen S Whitehead
- Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA
| | - Guruprasad R Medigeshi
- Bioassay laboratory and Clinical and Cellular Virology lab, Translational Health Science and Technology Institute, Faridabad, Haryana, India.
| |
Collapse
|
6
|
Shukla S, Yadav PD, Patil S, Jain A, Aggarawal V. Atypical clinical presentation of Zika virus from India. INDIAN J PATHOL MICR 2023; 66:673-674. [PMID: 37530371 DOI: 10.4103/ijpm.ijpm_144_22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Affiliation(s)
- Suruchi Shukla
- Department of Microbiology, King Georges' Medical University, Lucknow, Uttar Pradesh, India
| | - Pragya D Yadav
- Department of Maximum Containment Facility, National Institute of Virology, Pune, Maharashtra, India
| | - Sunita Patil
- Department of Microbiology, 7 Air Force Hospital, Kanpur, Uttar Pradesh, India
| | - Amita Jain
- Department of Microbiology, King Georges' Medical University, Lucknow, Uttar Pradesh, India
| | - Vikasendu Aggarawal
- Directorate of Medical and Health Services, Integrated Disease Surveillance, IDSP, Uttar Pradesh, India
| |
Collapse
|
7
|
Yadav PD, Kaur H, Gupta N, Sahay RR, Sapkal GN, Shete AM, Deshpande GR, Mohandas S, Majumdar T, Patil S, Pandit P, Kumar A, Nyayanit DA, Sreelatha KH, Manjusree S, Sami H, Khan HM, Malhotra A, Dhingra K, Gadepalli R, Sudha Rani V, Singh MK, Joshi Y, Dudhmal M, Duggal N, Chabbra M, Dar L, Gawande P, Yemul J, Kalele K, Arjun R, Nagamani K, Borkakoty B, Sahoo G, Praharaj I, Dutta S, Barde P, Jaryal SC, Rawat V. Zika a Vector Borne Disease Detected in Newer States of India Amidst the COVID-19 Pandemic. Front Microbiol 2022; 13:888195. [PMID: 35756041 PMCID: PMC9226610 DOI: 10.3389/fmicb.2022.888195] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2022] [Accepted: 05/02/2022] [Indexed: 11/13/2022] Open
Abstract
Background During the second wave of the COVID-19 pandemic, outbreaks of Zika were reported from Kerala, Uttar Pradesh, and Maharashtra, India in 2021. The Dengue and Chikungunya negative samples were retrospectively screened to determine the presence of the Zika virus from different geographical regions of India. Methods During May to October 2021, the clinical samples of 1475 patients, across 13 states and a union territory of India were screened and re-tested for Dengue, Chikungunya and Zika by CDC Trioplex Real time RT-PCR. The Zika rRTPCR positive samples were further screened with anti-Zika IgM and Plaque Reduction Neutralization Test. Next generation sequencing was used for further molecular characterization. Results The positivity was observed for Zika (67), Dengue (121), and Chikungunya (10) amongst screened cases. The co-infections of Dengue/Chikungunya, Dengue/Zika, and Dengue/Chikungunya/Zika were also observed. All Zika cases were symptomatic with fever (84%) and rash (78%) as major presenting symptoms. Of them, four patients had respiratory distress, one presented with seizures, and one with suspected microcephaly at birth. The Asian Lineage of Zika and all four serotypes of Dengue were found in circulation. Conclusion Our study indicates the spread of the Zika virus to several states of India and an urgent need to strengthen its surveillance.
Collapse
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Harmanmeet Kaur
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India
| | - Nivedita Gupta
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India
| | - Rima R Sahay
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Gajanan N Sapkal
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Anita M Shete
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Gururaj R Deshpande
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | | | - Triparna Majumdar
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Savita Patil
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Priyanka Pandit
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Abhinendra Kumar
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Dimpal A Nyayanit
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - K H Sreelatha
- Virus Research and Diagnostic Laboratory, Government Medical College, Thiruvananthapuram, India
| | - S Manjusree
- Virus Research and Diagnostic Laboratory, Government Medical College, Thiruvananthapuram, India
| | - Hiba Sami
- Virus Research and Diagnostic Laboratory, Jawaharlal Nehru Medical College, Aligarh, India
| | - Haris Mazoor Khan
- Virus Research and Diagnostic Laboratory, Jawaharlal Nehru Medical College, Aligarh, India
| | - Anuradha Malhotra
- Virus Research and Diagnostic Laboratory, Government Medical College, Amritsar, India
| | - Kanwardeep Dhingra
- Virus Research and Diagnostic Laboratory, Government Medical College, Amritsar, India
| | - Ravisekhar Gadepalli
- Virus Research and Diagnostic Laboratory, All India Institute of Medical Sciences, Jodhpur, India
| | - V Sudha Rani
- Virus Research and Diagnostic Laboratory, Osmania Medical College Hyderabad, Hyderabad, India
| | - Manoj Kumar Singh
- Virus Research and Diagnostic Laboratory, Rajendra Institute of Medical Sciences, Ranchi, India
| | - Yash Joshi
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Manisha Dudhmal
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Nandini Duggal
- Virus Research and Diagnostic Laboratory, Atal Bihari Vajpayee Institute of Medical Sciences & Dr. Ram Manohar Lohia Hospital, New Delhi, India
| | - Mala Chabbra
- Virus Research and Diagnostic Laboratory, Atal Bihari Vajpayee Institute of Medical Sciences & Dr. Ram Manohar Lohia Hospital, New Delhi, India
| | - Lalit Dar
- Virus Research and Diagnostic Laboratory, All India Institute of Medical Sciences, New Delhi, India
| | - Pranita Gawande
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Jyoti Yemul
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Kaumudi Kalele
- Indian Council of Medical Research, National Institute of Virology, Pune, India
| | | | - K Nagamani
- Virus Research and Diagnostic Laboratory, Gandhi Medical College, Secunderabad, India
| | - Biswa Borkakoty
- Virus Research and Diagnostic Laboratory, ICMR-Regional Medical Research Centre, Dibrugarh, India
| | - Ganesh Sahoo
- Virus Research and Diagnostic Laboratory, ICMR-Rajendra Memorial Research Institute of Medical Sciences, Patna, India
| | - Ira Praharaj
- Virus Research and Diagnostic Laboratory, ICMR-Regional Medical Research Centre, Bhubaneswar, India
| | - Shanta Dutta
- Virus Research and Diagnostic Laboratory, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India
| | - Pradip Barde
- Virus Research and Diagnostic Laboratory, ICMR-National Institute of Research in Tribal Health, Jabalpur, India
| | - S C Jaryal
- Virus Research and Diagnostic Laboratory, Dr. Rajendra Prasad Government Medical College, Tanda, India
| | - Vinita Rawat
- Virus Research and Diagnostic Laboratory, Government Medical College, Haldwani, India
| |
Collapse
|
8
|
Yadav PD, Niyas VKM, Arjun R, Sahay RR, Shete AM, Sapkal GN, Pawar S, Patil DY, Gupta N, Abraham P. Detection of Zika virus disease in Thiruvananthapuram, Kerala, India 2021 during second wave of COVID-19 pandemic. J Med Virol 2022; 94:2346-2349. [PMID: 35102566 PMCID: PMC9015449 DOI: 10.1002/jmv.27638] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2021] [Revised: 01/07/2022] [Accepted: 01/27/2022] [Indexed: 11/09/2022]
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| | | | - Rajalakshmi Arjun
- Kerala Institute of Medical Sciences and Health (KIMSHEALTH), Thiruvananthapuram, Kerala, India, Pin-695029
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| | - Gajanan N Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| | - Shailesh Pawar
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| | - Nivedita Gupta
- ndian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi, India, Pin-110029
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| |
Collapse
|
9
|
OUP accepted manuscript. Trans R Soc Trop Med Hyg 2022; 116:974-977. [DOI: 10.1093/trstmh/trac022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2021] [Revised: 12/28/2021] [Accepted: 03/11/2022] [Indexed: 11/15/2022] Open
|